| Protocol Number |
Title |
2003NT036
|
ALTE03N1 Key Adverse Events After Childhood Cancer (COG study) |
2003NT049
|
ABTR01B1 A Children's Oncology Group Protocol for Collecting and Banking Pediatric Research Specimens Including Rare Pediatric Tumors |
2003NT064
|
Metabolic Syndrome in Childhood Cancer Survivors |
2005LS068
|
Phase I Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies |
2005NT018
|
A Randomized Phase II Study of Zoledronic Acid (Zometa) in the Prevention of Osteoporosis In Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (Study # CZOL446EUS29, MT2005-06) |
2006LS032
|
MT2005-21: Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors |
2006NT014
|
Bupropion + Placebo or Bupropion + Naltrexone for Smoking Cessation |
2006NT018
|
Menstrual Phase and Depression Symptoms in Acute Smoking Abstinence |
2007CG023
|
MT2006-25: CTN 0403 - A Randomized Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Acute Non-Infectious Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome) Following Allogeneic Cell Transplantation |
2007LS022
|
MT2006-01: Phase I Study of Infusion of Umbilical Cord Blood (UCB) Derived CD25+ CD4+ T-Regulatory (Treg) Cells After Non-Myeloablative Cord Blood Transplantation |
2007LS065
|
MT2007-11R: Open-Label Single-Arm Pilot Study of Deferasirox (Exjade) in Adult Allogenic Hematopoietic Stem Cell Transplant Recipients with Transfusional Iron Overload |
2007LS072
|
MT2007-07: Conditioning for Graft Failure after Hematopoietic Stem Cell Transplantation |
2007NT032
|
Human Laboratory Study of Varenicline in Smokers |
2007NT042
|
The clearance of tobacco carcinogen biomarkers after smoking cessation |
2007NT053
|
Promoting Home Smoking Restrictions: Biomarker Feedback to Cohabitating Smoking and Non-Smoking Adults. |
2007NT059
|
ABTR06C1: Pharmakokinetics of Daunomycin in Children |
2007NT123
|
2007-18R: Chronic GVHD Cohort Protocol |
2008CG164
|
COG ADVL0812 A Phase I Study of MLN8237, an Oral Selective Small Molecule Inhibitor of Aurora A Kinase, in Children with Relapsed/Refractory Solid Tumors and Leukemia |
2008IS034
|
A Prospective, Randomized Trial Comparing the Efficacy of Anidulafungin and Voriconazole in Combination to that of Voriconazole Alone When Used for Primary Therapy of Proven or Probable Invasive Aspergillosis |
2008NTCG101
|
COG ANBL00B1 "Neuroblastoma Biology Studies" |
2008NTLS087
|
2008-13R: In Vivo Measurement of DNA and Protein Adducts in Fanconi Anemia and Non-Fanconi Anemia Patients Undergoing Hematopoietic Stem Cell Transplantation |
2009CG038
|
COG ADVL0813, A Phase I Study of IMC-A12 (Anti-Insulin-Like Growth Factor-I Receptor Monoclonal Antibody) in Combination with CCI-779 (Temsirolimus) in Pediatric Patients with Recurrent or Refractory Solid Tumors |
2009CG113
|
ADVL0912: A Phase 1/2 Study of PF-02341066, an Oral Small Molecule Inhibitor of Anaplastic Lymphoma Kinase (ALK) and C-Met, in Children with Relapsed/Refractory Solid Tumors and Anaplastic Large Cell Lymphoma |
2009NTCG026
|
COG ALTE05N1 Umbrella Long-Term Follow-Up Protocol |
MT2002-07
|
Allogeneic Hematopoietic Stem Cell Transplant For Patients with High Risk Hemoglobinopathy Using a Non-Myeloablative Preparative Regimen. |
Clinical Trials Help